MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..

Remeron (Mirtazapine)

Company: Organon
Approval Status: Approved June 1996
Treatment for: depression
Areas: Diabetes / Endocrinology; Psychiatry / Psychiatric
Possible similar drugs: Remeron SolTab

| General Information | Clinical Results | Side Effects | Mechanism of Action |

General Information

Remeron has been approved for the treatment of depression.

Clinical Results

The FDA clearance of Remeron is based on efficacy data from clinical trials involving approximately 3,000 people. Results from placebo and amitriptyline-controlled clinical trials supported the conclusion that Remeron provides effective relief of depression.

Side Effects

Side effects observed in clinical trials were mostly mild and generally have not caused subjects to stop taking Remeron. The commonly reported drug-related side effects in subjects taking Remeron were somnolence, increased appetite, weight gain, and dizziness.

Mechanism of Action

Remeron is the first agent in a new class of anti-depressants. Remeron stimulates norepinephrine and serotonin release while also blocking two serotonin receptors (5-HT2 and 5-HT3).

< back to top

Remeron Drug Information

The Remeron drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.